DOMAB

Welcome to the Brand page for “DOMAB”, which is offered here for Research and development services in the field of antibodies;.

Its status is currently believed to be active. Its class is unavailable. “DOMAB” is believed to be currently owned by “Boston Immune Technologies and Therapeutics, Inc.”


Owner:
BOSTON IMMUNE TECHNOLOGIES AND THERAPEUTICS, INC.
Owner Details
Description:
Research and development services in the field of antibodies;
Categories: RESEARCH DEVELOPMENT SERVICES